Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 2475 entries
Sorted by: Best Match Show Resources per page
Comparison of soymilk and probiotic soymilk effects on serum high-density lipoprotein cholesterol and low-density lipoprotein cholesterol in diabetic Wistar rats.

ARYA atherosclerosis

Babashahi M, Mirlohi M, Ghiasvand R, Azadbakht L.
PMID: 26261455
ARYA Atheroscler. 2015 Feb;11:88-93.

BACKGROUND: Soy milk (SM) and its fermented products are identified as rich sources of bioactive compounds helping to manage and to reduce the risk of chronic disease. This study aimed to compare the effects of SM and probiotic SM...

Cite
Babashahi M, Mirlohi M, Ghiasvand R, et al. Comparison of soymilk and probiotic soymilk effects on serum high-density lipoprotein cholesterol and low-density lipoprotein cholesterol in diabetic Wistar rats. ARYA Atheroscler. 2015;11:88-93
Babashahi, M., Mirlohi, M., Ghiasvand, R., & Azadbakht, L. (2015). Comparison of soymilk and probiotic soymilk effects on serum high-density lipoprotein cholesterol and low-density lipoprotein cholesterol in diabetic Wistar rats. ARYA atherosclerosis, 1188-93.
Babashahi, Mina, et al. "Comparison of soymilk and probiotic soymilk effects on serum high-density lipoprotein cholesterol and low-density lipoprotein cholesterol in diabetic Wistar rats." ARYA atherosclerosis vol. 11 (2015): 88-93.
Babashahi M, Mirlohi M, Ghiasvand R, Azadbakht L. Comparison of soymilk and probiotic soymilk effects on serum high-density lipoprotein cholesterol and low-density lipoprotein cholesterol in diabetic Wistar rats. ARYA Atheroscler. 2015 Feb;11:88-93. PMID: 26261455; PMCID: PMC4530662.
Copy Download .nbib Format: NLM
The Prevalence of Diabetes Mellitus in COPD Patients with Severe and Very Severe Stage of the Disease.

Open access Macedonian journal of medical sciences

Stojkovikj J, Zafirova-Ivanovska B, Kaeva B, Anastasova S, Angelovska I, Jovanovski S, Stojkovikj D.
PMID: 27335596
Open Access Maced J Med Sci. 2016 Jun 15;4(2):253-8. doi: 10.3889/oamjms.2016.060. Epub 2016 May 22.

AIM: The aim of the study was to investigate the prevalence of diabetes mellitus in privies diagnosed chronic obstructive pulmonary disease (COPD) patients with severe and very severe disease, which ware stable.METHODS: We investigated 100 subjects, all of them...

Cite
Stojkovikj J, Zafirova-Ivanovska B, Kaeva B, et al. The Prevalence of Diabetes Mellitus in COPD Patients with Severe and Very Severe Stage of the Disease. Open Access Maced J Med Sci. 2016;4(2):253-8doi: 10.3889/oamjms.2016.060.
Stojkovikj, J., Zafirova-Ivanovska, B., Kaeva, B., Anastasova, S., Angelovska, I., Jovanovski, S., & Stojkovikj, D. (2016). The Prevalence of Diabetes Mellitus in COPD Patients with Severe and Very Severe Stage of the Disease. Open access Macedonian journal of medical sciences, 4(2), 253-8. https://doi.org/10.3889/oamjms.2016.060
Stojkovikj, Jagoda, et al. "The Prevalence of Diabetes Mellitus in COPD Patients with Severe and Very Severe Stage of the Disease." Open access Macedonian journal of medical sciences vol. 4,2 (2016): 253-8. doi: https://doi.org/10.3889/oamjms.2016.060
Stojkovikj J, Zafirova-Ivanovska B, Kaeva B, Anastasova S, Angelovska I, Jovanovski S, Stojkovikj D. The Prevalence of Diabetes Mellitus in COPD Patients with Severe and Very Severe Stage of the Disease. Open Access Maced J Med Sci. 2016 Jun 15;4(2):253-8. doi: 10.3889/oamjms.2016.060. Epub 2016 May 22. PMID: 27335596; PMCID: PMC4908741.
Copy Download .nbib Format: NLM
The Level of Cholesterol in COPD Patients with Severe and Very Severe Stage of the Disease.

Open access Macedonian journal of medical sciences

Zafirova-Ivanovska B, Stojkovikj J, Dokikj D, Anastasova S, Debresliovska A, Zejnel S, Stojkovikj D.
PMID: 27335600
Open Access Maced J Med Sci. 2016 Jun 15;4(2):277-82. doi: 10.3889/oamjms.2016.063. Epub 2016 May 24.

BACKGROUND: High blood cholesterol is part of metabolic syndrome and can be caused by medical conditions or bad dietary habits.AIM: The aim of the study was to investigate the prevalence of hypercholesterolemia in privies diagnosed patients with the severe...

Cite
Zafirova-Ivanovska B, Stojkovikj J, Dokikj D, et al. The Level of Cholesterol in COPD Patients with Severe and Very Severe Stage of the Disease. Open Access Maced J Med Sci. 2016;4(2):277-82doi: 10.3889/oamjms.2016.063.
Zafirova-Ivanovska, B., Stojkovikj, J., Dokikj, D., Anastasova, S., Debresliovska, A., Zejnel, S., & Stojkovikj, D. (2016). The Level of Cholesterol in COPD Patients with Severe and Very Severe Stage of the Disease. Open access Macedonian journal of medical sciences, 4(2), 277-82. https://doi.org/10.3889/oamjms.2016.063
Zafirova-Ivanovska, Beti, et al. "The Level of Cholesterol in COPD Patients with Severe and Very Severe Stage of the Disease." Open access Macedonian journal of medical sciences vol. 4,2 (2016): 277-82. doi: https://doi.org/10.3889/oamjms.2016.063
Zafirova-Ivanovska B, Stojkovikj J, Dokikj D, Anastasova S, Debresliovska A, Zejnel S, Stojkovikj D. The Level of Cholesterol in COPD Patients with Severe and Very Severe Stage of the Disease. Open Access Maced J Med Sci. 2016 Jun 15;4(2):277-82. doi: 10.3889/oamjms.2016.063. Epub 2016 May 24. PMID: 27335600; PMCID: PMC4908745.
Copy Download .nbib Format: NLM
Efficacy of low- and moderate-intensity statins for achieving low- density lipoprotein cholesterol targets in Thai type 2 diabetic patients.

Journal of diabetes and metabolic disorders

Thongtang N, Sitthananun C, Sriussadaporn S, Nitiyanant W.
PMID: 28289653
J Diabetes Metab Disord. 2017 Feb 13;16:6. doi: 10.1186/s40200-017-0290-x. eCollection 2017.

BACKGROUND: Low dose statins are commonly used among Asians, because plasma low-density lipoprotein cholesterol (LDL-C) reductions similar to those observed in Westerners are achieved at lower doses. We aimed to assess the efficacy of low- and moderate-intensity statins for...

Cite
Thongtang N, Sitthananun C, Sriussadaporn S, et al. Efficacy of low- and moderate-intensity statins for achieving low- density lipoprotein cholesterol targets in Thai type 2 diabetic patients. J Diabetes Metab Disord. 2017;16:6doi: 10.1186/s40200-017-0290-x.
Thongtang, N., Sitthananun, C., Sriussadaporn, S., & Nitiyanant, W. (2017). Efficacy of low- and moderate-intensity statins for achieving low- density lipoprotein cholesterol targets in Thai type 2 diabetic patients. Journal of diabetes and metabolic disorders, 166. https://doi.org/10.1186/s40200-017-0290-x
Thongtang, Nuntakorn, et al. "Efficacy of low- and moderate-intensity statins for achieving low- density lipoprotein cholesterol targets in Thai type 2 diabetic patients." Journal of diabetes and metabolic disorders vol. 16 (2017): 6. doi: https://doi.org/10.1186/s40200-017-0290-x
Thongtang N, Sitthananun C, Sriussadaporn S, Nitiyanant W. Efficacy of low- and moderate-intensity statins for achieving low- density lipoprotein cholesterol targets in Thai type 2 diabetic patients. J Diabetes Metab Disord. 2017 Feb 13;16:6. doi: 10.1186/s40200-017-0290-x. eCollection 2017. PMID: 28289653; PMCID: PMC5307884.
Copy Download .nbib Format: NLM
Increased Waist-to-height Ratio May Contribute to Age-related Increase in Cardiovascular Risk Factors.

International journal of preventive medicine

Akhlaghi M, Kamali M, Dastsouz F, Sadeghi F, Amanat S.
PMID: 27195100
Int J Prev Med. 2016 Apr 27;7:68. doi: 10.4103/2008-7802.181328. eCollection 2016.

BACKGROUND: The risk of cardiovascular diseases (CVDs) increases with age. The objective was to determine whether lifestyle and dietary behaviors and anthropometric measures, which are affected by these behaviors, contribute to the increase of CVD risk factors across age...

Cite
Akhlaghi M, Kamali M, Dastsouz F, et al. Increased Waist-to-height Ratio May Contribute to Age-related Increase in Cardiovascular Risk Factors. Int J Prev Med. 2016;7:68doi: 10.4103/2008-7802.181328.
Akhlaghi, M., Kamali, M., Dastsouz, F., Sadeghi, F., & Amanat, S. (2016). Increased Waist-to-height Ratio May Contribute to Age-related Increase in Cardiovascular Risk Factors. International journal of preventive medicine, 768. https://doi.org/10.4103/2008-7802.181328
Akhlaghi, Masoumeh, et al. "Increased Waist-to-height Ratio May Contribute to Age-related Increase in Cardiovascular Risk Factors." International journal of preventive medicine vol. 7 (2016): 68. doi: https://doi.org/10.4103/2008-7802.181328
Akhlaghi M, Kamali M, Dastsouz F, Sadeghi F, Amanat S. Increased Waist-to-height Ratio May Contribute to Age-related Increase in Cardiovascular Risk Factors. Int J Prev Med. 2016 Apr 27;7:68. doi: 10.4103/2008-7802.181328. eCollection 2016. PMID: 27195100; PMCID: PMC4863399.
Copy Download .nbib Format: NLM
Increased Plasma Dipeptidyl Peptidase-4 Activities in Patients with Coronary Artery Disease.

PloS one

Yang G, Li Y, Cui L, Jiang H, Li X, Jin C, Jin D, Zhao G, Jin J, Sun R, Piao L, Xu W, Fang C, Lei Y, Yuan K, Xuan C, Ding D, Cheng X.
PMID: 27654253
PLoS One. 2016 Sep 21;11(9):e0163027. doi: 10.1371/journal.pone.0163027. eCollection 2016.

Dipeptidyl peptidase-4 (DPP4) is one of the most potent mammalian serine proteases participated in the pathogenesis of subclinical atherosclerosis. Here we investigated whether the plasma soluble form of DPP4 is associated with the prevalence of coronary artery disease (CAD)...

Cite
Yang G, Li Y, Cui L, et al. Increased Plasma Dipeptidyl Peptidase-4 Activities in Patients with Coronary Artery Disease. PLoS One. 2016;11(9):e0163027doi: 10.1371/journal.pone.0163027.
Yang, G., Li, Y., Cui, L., Jiang, H., Li, X., Jin, C., Jin, D., Zhao, G., Jin, J., Sun, R., Piao, L., Xu, W., Fang, C., Lei, Y., Yuan, K., Xuan, C., Ding, D., & Cheng, X. (2016). Increased Plasma Dipeptidyl Peptidase-4 Activities in Patients with Coronary Artery Disease. PloS one, 11(9), e0163027. https://doi.org/10.1371/journal.pone.0163027
Yang, Guang, et al. "Increased Plasma Dipeptidyl Peptidase-4 Activities in Patients with Coronary Artery Disease." PloS one vol. 11,9 (2016): e0163027. doi: https://doi.org/10.1371/journal.pone.0163027
Yang G, Li Y, Cui L, Jiang H, Li X, Jin C, Jin D, Zhao G, Jin J, Sun R, Piao L, Xu W, Fang C, Lei Y, Yuan K, Xuan C, Ding D, Cheng X. Increased Plasma Dipeptidyl Peptidase-4 Activities in Patients with Coronary Artery Disease. PLoS One. 2016 Sep 21;11(9):e0163027. doi: 10.1371/journal.pone.0163027. eCollection 2016. PMID: 27654253; PMCID: PMC5031423.
Copy Download .nbib Format: NLM
Martin's Equation as the Most Suitable Method for Estimation of Low-Density Lipoprotein Cholesterol Levels in Korean Adults.

Korean journal of family medicine

Kang M, Kim J, Lee SY, Kim K, Yoon J, Ki H.
PMID: 29026486
Korean J Fam Med. 2017 Sep;38(5):263-269. doi: 10.4082/kjfm.2017.38.5.263. Epub 2017 Sep 22.

BACKGROUND: Friedewald equation is the most widely used method for estimating low-density lipoprotein cholesterol (LDL-C) level. However, due to potential over- or underestimation, many studies have used a modified equation. This study aimed to compare estimates by 4 different...

Cite
Kang M, Kim J, Lee SY, et al. Martin's Equation as the Most Suitable Method for Estimation of Low-Density Lipoprotein Cholesterol Levels in Korean Adults. Korean J Fam Med. 2017;38(5):263-269doi: 10.4082/kjfm.2017.38.5.263.
Kang, M., Kim, J., Lee, S. Y., Kim, K., Yoon, J., & Ki, H. (2017). Martin's Equation as the Most Suitable Method for Estimation of Low-Density Lipoprotein Cholesterol Levels in Korean Adults. Korean journal of family medicine, 38(5), 263-269. https://doi.org/10.4082/kjfm.2017.38.5.263
Kang, Mijeong, et al. "Martin's Equation as the Most Suitable Method for Estimation of Low-Density Lipoprotein Cholesterol Levels in Korean Adults." Korean journal of family medicine vol. 38,5 (2017): 263-269. doi: https://doi.org/10.4082/kjfm.2017.38.5.263
Kang M, Kim J, Lee SY, Kim K, Yoon J, Ki H. Martin's Equation as the Most Suitable Method for Estimation of Low-Density Lipoprotein Cholesterol Levels in Korean Adults. Korean J Fam Med. 2017 Sep;38(5):263-269. doi: 10.4082/kjfm.2017.38.5.263. Epub 2017 Sep 22. PMID: 29026486; PMCID: PMC5637217.
Copy Download .nbib Format: NLM
LDL-cholesterol measurement in diabetic type 2 patients: a comparison between direct assay and popular equations.

Journal of diabetes and metabolic disorders

Razi F, Forouzanfar K, Bandarian F, Nasli-Esfahani E.
PMID: 29142884
J Diabetes Metab Disord. 2017 Nov 03;16:43. doi: 10.1186/s40200-017-0326-2. eCollection 2017.

BACKGROUND: Low density lipoprotein -Cholesterol (LDL-C) is one of the main factors for assessment of cardiovascular disease risk and it is more important in diabetic patients. Various methods are currently used for LDL-C measurements which are compared in this...

Cite
Razi F, Forouzanfar K, Bandarian F, et al. LDL-cholesterol measurement in diabetic type 2 patients: a comparison between direct assay and popular equations. J Diabetes Metab Disord. 2017;16:43doi: 10.1186/s40200-017-0326-2.
Razi, F., Forouzanfar, K., Bandarian, F., & Nasli-Esfahani, E. (2017). LDL-cholesterol measurement in diabetic type 2 patients: a comparison between direct assay and popular equations. Journal of diabetes and metabolic disorders, 1643. https://doi.org/10.1186/s40200-017-0326-2
Razi, Farideh, et al. "LDL-cholesterol measurement in diabetic type 2 patients: a comparison between direct assay and popular equations." Journal of diabetes and metabolic disorders vol. 16 (2017): 43. doi: https://doi.org/10.1186/s40200-017-0326-2
Razi F, Forouzanfar K, Bandarian F, Nasli-Esfahani E. LDL-cholesterol measurement in diabetic type 2 patients: a comparison between direct assay and popular equations. J Diabetes Metab Disord. 2017 Nov 03;16:43. doi: 10.1186/s40200-017-0326-2. eCollection 2017. PMID: 29142884; PMCID: PMC5670525.
Copy Download .nbib Format: NLM
Serum prolidase activity is associated with non-diabetic metabolic syndrome.

Diabetology & metabolic syndrome

Tabur S, Oguz E, Eren MA, Korkmaz H, Savas E, Aksoy N, Sabuncu T.
PMID: 25540672
Diabetol Metab Syndr. 2014 Dec 17;6(1):142. doi: 10.1186/1758-5996-6-142. eCollection 2014.

OBJECTIVE: The aim of this study was to determine the role of serum prolidase activity and the possible association with oxidative stress parameters in non-diabetic metabolic syndrome.METHODS: 30 obese patients without metabolic syndrome (MetS), 34 non-diabetic obese patients with...

Cite
Tabur S, Oguz E, Eren MA, et al. Serum prolidase activity is associated with non-diabetic metabolic syndrome. Diabetol Metab Syndr. 2014;6(1):142doi: 10.1186/1758-5996-6-142.
Tabur, S., Oguz, E., Eren, M. A., Korkmaz, H., Savas, E., Aksoy, N., & Sabuncu, T. (2014). Serum prolidase activity is associated with non-diabetic metabolic syndrome. Diabetology & metabolic syndrome, 6(1), 142. https://doi.org/10.1186/1758-5996-6-142
Tabur, Suzan, et al. "Serum prolidase activity is associated with non-diabetic metabolic syndrome." Diabetology & metabolic syndrome vol. 6,1 (2014): 142. doi: https://doi.org/10.1186/1758-5996-6-142
Tabur S, Oguz E, Eren MA, Korkmaz H, Savas E, Aksoy N, Sabuncu T. Serum prolidase activity is associated with non-diabetic metabolic syndrome. Diabetol Metab Syndr. 2014 Dec 17;6(1):142. doi: 10.1186/1758-5996-6-142. eCollection 2014. PMID: 25540672; PMCID: PMC4276100.
Copy Download .nbib Format: NLM
Physiological changes during fasting in Ramadan.

JPMA. The Journal of the Pakistan Medical Association

Meo SA, Hassan A.
PMID: 26013791
J Pak Med Assoc. 2015 May;65(5):S6-S14.

Fasting during Ramadan is one of the five fundamental pillars of Islam and mandatory for all healthy adult Muslims to fast from sunrise to sunset for a period of a month. During fasting, Muslims are required to refrain from...

Cite
Meo SA, Hassan A. Physiological changes during fasting in Ramadan. J Pak Med Assoc. 2015;65(5):S6-S14
Meo, S. A., & Hassan, A. (2015). Physiological changes during fasting in Ramadan. JPMA. The Journal of the Pakistan Medical Association, 65(5), S6-S14.
Meo, Sultan Ayoub, and Hassan, Asim. "Physiological changes during fasting in Ramadan." JPMA. The Journal of the Pakistan Medical Association vol. 65,5 (2015): S6-S14.
Meo SA, Hassan A. Physiological changes during fasting in Ramadan. J Pak Med Assoc. 2015 May;65(5):S6-S14. PMID: 26013791.
Copy Download .nbib Format: NLM
Serum vitamin d status and its relationship to metabolic parameters in patients with type 2 diabetes mellitus.

Chonnam medical journal

Yu JR, Lee SA, Lee JG, Seong GM, Ko SJ, Koh G, Kong MH, Park KY, Kim BJ, Lim DM, Lee DH.
PMID: 22977752
Chonnam Med J. 2012 Aug;48(2):108-15. doi: 10.4068/cmj.2012.48.2.108. Epub 2012 Aug 24.

The potential relationship between vitamin D (VitD) status and metabolic control in patients with type 2 diabetes mellitus (T2DM) warrants further study. We aimed to evaluate the relationship between the serum 25-hydroxyvitamin D [25(OH)D] level and various parameters in...

Cite
Yu JR, Lee SA, Lee JG, et al. Serum vitamin d status and its relationship to metabolic parameters in patients with type 2 diabetes mellitus. Chonnam Med J. 2012;48(2):108-15doi: 10.4068/cmj.2012.48.2.108.
Yu, J. R., Lee, S. A., Lee, J. G., Seong, G. M., Ko, S. J., Koh, G., Kong, M. H., Park, K. Y., Kim, B. J., Lim, D. M., & Lee, D. H. (2012). Serum vitamin d status and its relationship to metabolic parameters in patients with type 2 diabetes mellitus. Chonnam medical journal, 48(2), 108-15. https://doi.org/10.4068/cmj.2012.48.2.108
Yu, Jung Re, et al. "Serum vitamin d status and its relationship to metabolic parameters in patients with type 2 diabetes mellitus." Chonnam medical journal vol. 48,2 (2012): 108-15. doi: https://doi.org/10.4068/cmj.2012.48.2.108
Yu JR, Lee SA, Lee JG, Seong GM, Ko SJ, Koh G, Kong MH, Park KY, Kim BJ, Lim DM, Lee DH. Serum vitamin d status and its relationship to metabolic parameters in patients with type 2 diabetes mellitus. Chonnam Med J. 2012 Aug;48(2):108-15. doi: 10.4068/cmj.2012.48.2.108. Epub 2012 Aug 24. PMID: 22977752; PMCID: PMC3434790.
Copy Download .nbib Format: NLM
Effects of policosanol on borderline to mildly elevated serum total cholesterol levels: a prospective, double-blind, placebo-controlled, parallel-group, comparative study.

Current therapeutic research, clinical and experimental

Castaño G, Más R, Fernández J, López E, Illnait J, Fernández L, Mesa M.
PMID: 24944402
Curr Ther Res Clin Exp. 2003 Sep;64(8):522-37. doi: 10.1016/j.curtheres.2003.09.002.

BACKGROUND: Hypercholesterolemia is a major risk factor for coronary heart disease. Clinical studies have shown that lowering elevated serum cholesterol levels, particularly low-density lipoprotein cholesterol (LDL-C), is beneficial for patients with borderline to mildly elevated serum total cholesterol (TC)...

Cite
Castaño G, Más R, Fernández J, et al. Effects of policosanol on borderline to mildly elevated serum total cholesterol levels: a prospective, double-blind, placebo-controlled, parallel-group, comparative study. Curr Ther Res Clin Exp. 2003;64(8):522-37doi: 10.1016/j.curtheres.2003.09.002.
Castaño, G., Más, R., Fernández, J., López, E., Illnait, J., Fernández, L., & Mesa, M. (2003). Effects of policosanol on borderline to mildly elevated serum total cholesterol levels: a prospective, double-blind, placebo-controlled, parallel-group, comparative study. Current therapeutic research, clinical and experimental, 64(8), 522-37. https://doi.org/10.1016/j.curtheres.2003.09.002
Castaño, Gladys, et al. "Effects of policosanol on borderline to mildly elevated serum total cholesterol levels: a prospective, double-blind, placebo-controlled, parallel-group, comparative study." Current therapeutic research, clinical and experimental vol. 64,8 (2003): 522-37. doi: https://doi.org/10.1016/j.curtheres.2003.09.002
Castaño G, Más R, Fernández J, López E, Illnait J, Fernández L, Mesa M. Effects of policosanol on borderline to mildly elevated serum total cholesterol levels: a prospective, double-blind, placebo-controlled, parallel-group, comparative study. Curr Ther Res Clin Exp. 2003 Sep;64(8):522-37. doi: 10.1016/j.curtheres.2003.09.002. PMID: 24944402; PMCID: PMC4053045.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 2475 entries